Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

BACKGROUND: Thrombopoietin receptor agonists (TPO‐RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count. OBJECTIVES: To develop expert consensus on when it is appropriate to consider tapering TPO‐RAs in I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: Cuker, Adam, Despotovic, Jenny M., Grace, Rachael F., Kruse, Caroline, Lambert, Michele P., Liebman, Howard A., Lyons, Roger M., McCrae, Keith R., Pullarkat, Vinod, Wasser, Jeffrey S., Beenhouwer, David, Gibbs, Sarah N., Yermilov, Irina, Broder, Michael S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles ‐ Hemostasis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7845076/
https://ncbi.nlm.nih.gov/pubmed/33537531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12457
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars